Abdul-Rahman Jazieh, Adda Bounedjar, Hikmat Abdel-Razeq, Elif Berna Koksoy, Jawaher Ansari, Arafat H Tfayli, Emad M Tashkandi, Wasil A Jastaniah, Mohamed Osama Alorabi, Amira D Darwish, Ahmed Magdy Rabea, Ashwaq Al Olayan, Fahad Ibnshamsah, Hassan Errihani, Mohammad Omar AlKaiyat, Fazal Hussain, Khaled Alkattan, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Hani Tamim
INTRODUCTION: Despite extensive studies of the impact of COVID-19 on patients with cancer, there is a dearth of information from the Middle East and North Africa (MENA) region. Our study aimed to report pertinent MENA COVID-19 and Cancer Registry (MCCR) findings on patient management and outcomes. METHODS: MCCR was adapted from the American Society of Clinical Oncology COVID-19 Registry to collect data specifically from patients with cancer and SARS-CoV-2 infection from 12 centers in eight countries including Saudi Arabia, Jordan, Lebanon, Turkey, Egypt, Algeria, United Arab Emirates, and Morocco...
May 2024: Journal of immunotherapy and precision oncology